Eli M. Wallace
Nessuna posizione attualmente
Storia della carriera di Eli M. Wallace
Precedenti posizioni note di Eli M. Wallace
Società | Posizione | Inizio | Fine |
---|---|---|---|
ARRAY TECHNOLOGIES, INC. | Corporate Officer/Principal | 01/01/2000 | 01/01/2011 |
BRIDGEBIO PHARMA, INC. | Direttore Tecnico/Scientifico/R&S | 09/12/2019 | - |
GSK PLC | Corporate Officer/Principal | - | - |
Glaxo Wellcome Plc | Corporate Officer/Principal | - | - |
NOVARTIS AG | Corporate Officer/Principal | - | - |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Corporate Officer/Principal | - | - |
PELOTON THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/05/2016 | - |
Formazione di Eli M. Wallace
Lawrence University | Undergraduate Degree |
Colorado State University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Svizzera | 3 |
Regno Unito | 3 |
Posizioni
Corporate Officer/Principal | 5 |
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Settori
Health Technology | 8 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
NOVARTIS AG | Health Technology |
GSK PLC | Health Technology |
BRIDGEBIO PHARMA, INC. | Health Technology |
Aziende private | 4 |
---|---|
Peloton Therapeutics, Inc.
Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Peloton Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in translating novel scientific insights into medicines for patients with cancer and other debilitating or life-threatening conditions. Its lead drug candidate is a small molecule which targets HIF-2a, a transcription factor implicated in the development and progression of renal and other cancers. The company was founded by Steven L. McKnight in August 2010 and is headquartered in Dallas, TX. | Health Technology |
Array BioPharma, Inc.
Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Health Technology |
Glaxo Wellcome Plc | Health Technology |
- Borsa valori
- Insiders
- Eli M. Wallace
- Esperienza